DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, ...

Trinity Biotech ( ($TRIB) ) has issued an announcement. Trinity Biotech announced a positive update regarding the U.S. government’s funding for ...

Trinity Biotech has announced that it received early approval from the World Health Organization to commence offshore manufacturing of its rapid HIV tests, TrinScreen HIV and Uni-Gold HIV.

Trinity Biotech has received earlier than expected approval from the World health Organization (WHO) to permit the later-stage manufacturing process of TrinScreen HIV and Uni-Gold HIV at its ...

Trinity Biotech is also transferring its HIV test production to an offshore manufacturing partner, a move approved by the World Health Organization. The company expects its preeclampsia and ...

Trinscreen HIV by Trinity Biotech Manufacturing, Determine HIV-1/2 (Abbott Diagnostics Medical Co.Ltd), Insti HIV-1/HIV-2 Antibody Test that is manufactured by BioLytical Laboratories Inc. Others ...

Trinity Biotech's two rapid HIV tests will continue to be funded under PEPFAR, a significant global initiative to combat HIV/AIDS. The company confirmed that other testing programs using their ...

Trinity Biotech has received earlier than expected approval from the World Health Organization (WHO) to permit the later-stage manufacturing process of TrinScreen HIV and Uni-Gold HIV at its ...